Upon activation, this axis maintains activation of miR- 378a-3p biogenesis, suppression of Sort1, increased stabilization and secretion of ApoB100, which subsequently facilitates hepatic secretion of VLDL and aggravates the pathogenesis of hyperlipidemia and hypolipoproteinemia. This evidence concerns the gene APOB and hypolipoproteinemia.